Results 221 to 230 of about 221,219 (252)

Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levels

The American Journal of Cardiology, 2001
Apolipoprotein B has been shown to be a better predictor of coronary heart disease than low-density lipoprotein (LDL) cholesterol, and non-high-density lipoprotein (non-HDL) cholesterol may also be a better parameter for coronary heart disease risk assessment and as a target for therapy.
C M, Ballantyne, T C, Andrews, J A, Hsia, J H, Kramer, C, Shear   +4 more
openaire   +2 more sources

Usefulness of Low-Density Lipoprotein Cholesterol and Non–High-Density Lipoprotein Cholesterol as Predictors of Cardiovascular Disease in Chinese

The American Journal of Cardiology, 2015
The predictive effect of non-high-density lipoprotein cholesterol (non-HDL-C) for cardiovascular disease (CVD) in Chinese general population has not been well demonstrated. The aim of our study was to examine the relation between non-HDL-C and CVD and compare the predictive effect of non-HDL-C and low-density lipoprotein cholesterol (LDL-C) for CVD in ...
Xiaoying, Gu, Xueli, Yang, Ying, Li, Jie, Cao, Jianxin, Li, Xiaoqing, Liu, Jichun, Chen, Chong, Shen, Ling, Yu, Jianfeng, Huang, Dongfeng, Gu   +10 more
openaire   +2 more sources

Non–High-Density Lipoprotein Cholesterol and Guidelines for Cholesterol Lowering in Recent History

Laboratory Medicine, 2019
AbstractBackgroundThe National Cholesterol Education Program (NCEP) released guidelines for treating cholesterol in 1988, 1994, and 2002. After a hiatus, the guidelines were released again in 2013, 2016, 2017, and 2018.MethodsIn this article, I review these guidelines, factors that affected their release, how they evolved, and why recommended treatment
openaire   +2 more sources

266 NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN THE METABOLIC SYNDROME.:

Journal of Investigative Medicine, 2006
Background The metabolic syndrome (MS) refers to a cluster of risk factors, including central obesity, elevated BP, insulin resistance, and dyslipidemia (DLP) characterized by elevated triglycerides (TG) and low high-density lipoprotein cholesterol (HDL).
J. Huang, R. Parish, H. Yu, P. F. Bass, I. Mansi, E. Kennen, T. Davis, D. Carden   +7 more
openaire   +1 more source

Non–high-density lipoprotein cholesterol reporting and goal attainment in primary care

Journal of Clinical Lipidology, 2012
The Adult Treatment Panel III guidelines established non-high-density lipoprotein cholesterol (non-HDL-C) as a secondary treatment target. However, non-HDL-C levels are not reported on standard lipid panels by many hospital-based and/or commercial biochemical laboratories.We determined whether reporting non-HDL-C was associated with improved non-HDL-C ...
Virani, Salim S., Wang, Degang, Woodard, LeChauncy D, Chitwood, Supicha S, Landrum, Cassie R, Zieve, Franklin J, Ballantyne, Christie M, Petersen, Laura A   +7 more
openaire   +2 more sources

Age-dependent associations of smoking and drinking with non–high-density lipoprotein cholesterol

Metabolism, 2010
Serum high-density lipoprotein (HDL) cholesterol levels are influenced by habitual smoking and drinking. Non-HDL cholesterol is known to be a potent predictor of cardiovascular disease. However, it remains to be determined whether the associations of non-HDL cholesterol with smoking and drinking differ with age.
Ichiro, Wakabayashi, Klaus, Groschner
openaire   +2 more sources

Non-high-density lipoprotein cholesterol: A target of lipid-lowering in dialysis patients

American Journal of Kidney Diseases, 2003
The finding of an increased prevalence and levels of atherogenic lipoproteins in the context of normal plasma total and low-density lipoprotein (LDL) cholesterol (LDL-C) levels in hemodialysis (HD) patients highlights the need to look beyond the basic assessment of plasma concentrations of total cholesterol and LDL-C.
Christoph, Wanner, Vera, Krane
openaire   +2 more sources

Usefulness of non–high-density lipoprotein cholesterol determinations in the diagnosis and treatment of dyslipidemia

The American Journal of Cardiology, 2003
N lipoprotein (non-HDL) cholesterol, calculated as total cholesterol minus highdensity lipoprotein (HDL) cholesterol, encompasses the apolipoprotein B (Apo B)–containing particles that promote atherosclerosis, including low-density lipoprotein (LDL) cholesterol, very-low-density lipoprotein (VLDL) cholesterol, lipoprotein (a), and intermediate-density ...
Glenn A, Hirsch, Roger S, Blumenthal
openaire   +2 more sources

Relative Efficacy of Antilipemic Agents in Non–High-Density Lipoprotein Cholesterol Reduction

Journal of Pharmacy Practice, 2012
The investigators sought to summarize the percentage reduction in non–high-density lipoprotein cholesterol (non-HDL-C) achieved with various antilipemic regimens and to determine whether certain antilipemic regimens have been proven more effective in lowering non-HDL-C.
Jennifer, Santee, Cameron, Lindsey, Heather, Pace   +2 more
openaire   +2 more sources

Non‐high‐density lipoprotein cholesterol as a cardiovascular risk screening tool in children

Pediatrics International, 2016
AbstractBackgroundNon‐high‐density lipoprotein cholesterol (non‐HDL‐C) is now recognized as a strong predictive factor for cardiovascular disease in adults, but there have been few reports on non‐HDL‐C in children.MethodsA total of 5853 4th and 7th grade schoolchildren were included in the screening for lifestyle‐related disease from 2010 to 2011 in ...
Ayumi, Miyazaki, Ayako, Oguri, Fukiko, Ichida   +2 more
openaire   +2 more sources